Project Grant R00AG076966
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$249K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The federal Project Grant award R61AG089049, funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults. The $311,341 grant will support a two-phase project - the first phase will involve semi-structured interviews with Latino adults and patients/caregivers to inform a population-based survey on cost and...
The federal Project Grant award R01AG082056 for $1,199,134 was made by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866). The award supports a study on the "Social Epigenetics of Alzheimer's Disease and Related Dementias in Latin American Countries (LAC)". The primary awardee is Weill Medical College of Cornell University, which has established sub-awards with Universidad Adolfo Ibanez (Chile), Pontificia Universidad Javeriana...
The National Institute on Aging (NIA) awarded a $499,796 Project Grant (CFDA 93.866 - Aging Research) to Clear Session, Inc. in partnership with UTHealth Houston. The goal of this 3-year project, beginning on Sep 25, 2024, is to develop an innovative digital visualization tool to enhance healthcare communication and engagement between Latino Alzheimer's disease and related dementias (ADRD) patients, their caregivers, and healthcare providers. The tool is designed to break down complex medical...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the cultural adaptation of a mobile caregiver intervention for Hispanic dementia caregivers. The $356,974 award, spanning from September 2024 to June 2029, aims to assess the needs of Hispanic Alzheimer's and related dementia (ADRD) informal caregivers and develop modifications to the "Brain CareNotes" mobile telehealth application. The goal is to integrate cultural factors that impact...
This federal Project Grant award of $205,030 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the associations between neighborhood social and built environments across the life course and Alzheimer's disease and related dementia (ADRD) outcomes among Hispanic older adults in the South Florida region. The key products and services to be delivered under this grant include: Characterizing the life course neighborhood social and built environment exposures...
This federal Project Grant award in the amount of $424,184 is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) to study racial and ethnic disparities in access to Alzheimer's Special Care Units (SCUs) in nursing homes and the impact of SCU access on health outcomes. The key objectives are to: 1) Examine disparities in SCU access among Black and Hispanic residents with Alzheimer's disease and related dementias (ADRD), 2) Understand how SCU access contributes to disparities...
This federal Project Grant award of $778,551 from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a research project to estimate a novel probabilistic dementia classification for over 10 million Medicare beneficiaries aged 65 and older. The objective is to better understand diagnostic disparities in Alzheimer's disease and related dementias, particularly among racial/ethnic minority and underserved rural populations. The project will leverage linked Health and...
The National Institute on Aging awarded a $505,115 Project Grant (CFDA 93.866 - Aging Research) to The Washington University to evaluate the feasibility and effectiveness of a culturally-adapted mindfulness-based program (MBP) for reducing Alzheimer's disease (AD) risk in Latinx older adults. The project will establish the efficacy of the MBP intervention, test for associated neurocognitive enhancements, and identify how AD biomarkers may moderate the benefits. The Washington University will...
The National Institute on Aging awarded a $5,448,356 Cooperative Agreement (Federal Grant Program CFDA 93.866 - Aging Research) to Rush University Medical Center to contribute genetic and cognitive function data to the Alzheimer's Disease Sequencing Project (ADSP). The project aims to (i) collect genetic data (GWAS and whole genome sequences) from nearly 20,000 participants in the Mexican Teachers Cohort study, and (ii) conduct genetic analyses to identify novel drivers of cognitive function...